|
 |
|
|||||||
|
|||||||||
© 2001 by the American Diabetes Association, Inc.
International Workshop on Lessons From Animal Models for Human Type 1 Diabetes
Identification of Insulin but Not Glutamic Acid Decarboxylase or IA-2 as Specific Autoantigens of Humoral Autoimmunity in Nonobese Diabetic Mice
1 Department of Medicine, Isituto Scientifico San Raffaele, Milan, Italy, and the Diabetes Research Institute, Munich, Germany
2 Department of Pathology, University of Florida, Gainesville, Florida
3 Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado
4 Jackson Laboratory, Bar Harbor, Maine
5 Autoimmunity and Transplantation Division, the Walter and Eliza Hall Institute of Medical Research, Victoria, Australia
6 Department of Microbiology & Immunology, University of Western Ontario, London, Canada
Several self-antigens have been reported as targets of the autoimmune response in nonobese diabetic (NOD) mice. The aim of this workshop was to identify autoantibody assays that could provide useful markers of autoimmunity in this animal model for type 1 diabetes. More than 400 serum samples from NOD (4, 8, and 12 weeks of age and at diabetes onset), BALB/c, and B6 mice were collected from six separate animal facilities, coded, and distributed to five laboratories for autoantibody measurement. Insulin autoantibodies (IAA) were measured by radiobinding assay (RBA) by four laboratories and by enzyme-linked immunosorbent assay (ELISA) in one laboratory. Using the 99th percentile of BALB/c and B6 control mice as the threshold definition of positivity, IAA by RBA were detected in NOD mice at frequencies ranging from 10 to 30% at age 4 weeks, from 26 to 56% at 8 weeks, from 42 to 56% at 12 weeks, and from 15 to 75% at diabetes onset. With ELISA, IAA signals differed significantly between control mouse strains and increased with age in both control and NOD mice, with frequencies in NOD animals being 0% at 4 weeks, 14% at 8 weeks, 19% at 12 weeks, and 42% at diabetes onset. For IAA, the ELISA results were relatively discordant with those of RBA. GAD autoantibody (GADA) and IA-2 autoantibody (IA-2A) signals obtained by RBA were low (maximum 2.5% of total) but were increased in NOD mice compared with control mice at diabetes onset (GADA 29–50%; IA-2A 36–47%). ELISA also detected GADA (42%) and IA-2A (50%) at diabetes onset, with results concordant with those of RBA. Remarkably, GADA and IA-2A frequencies varied significantly with respect to the source colony of NOD mice. Furthermore, whereas neither GADA nor IA-2A correlated with IAA, there was strong concordance between GADA and IA-2A in individual mice. Sera with increased binding to GAD and IA-2 also had increased binding to the unrelated antigen myelin oligodendrocyte glycoprotein, and binding to GAD could not be inhibited with excess unlabeled antigen, suggesting nonspecific interactions. In sum, this workshop demonstrated that IAA measured by sensitive RBA are a marker of autoimmunity in NOD mice and draw into question the true nature of GADA and IA-2A in this animal model.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Martinuzzi, G. Novelli, M. Scotto, P. Blancou, J.-M. Bach, L. Chaillous, G. Bruno, L. Chatenoud, P. van Endert, and R. Mallone The Frequency and Immunodominance of Islet-Specific CD8+ T-cell Responses Change after Type 1 Diabetes Diagnosis and Treatment Diabetes, May 1, 2008; 57(5): 1312 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Blancou, R. Mallone, E. Martinuzzi, S. Severe, S. Pogu, G. Novelli, G. Bruno, B. Charbonnel, M. Dolz, L. Chaillous, et al. Immunization of HLA Class I Transgenic Mice Identifies Autoantigenic Epitopes Eliciting Dominant Responses in Type 1 Diabetes Patients J. Immunol., June 1, 2007; 178(11): 7458 - 7466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. O. ROEP Are Insights Gained from NOD Mice Sufficient to Guide Clinical Translation?: Another Inconvenient Truth Ann. N.Y. Acad. Sci., April 1, 2007; 1103(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Puertas, J. Carrillo, X. Pastor, R. M. Ampudia, A. Alba, R. Planas, R. Pujol-Borrell, M. Vives-Pi, and J. Verdaguer Phenotype and Functional Characteristics of Islet-Infiltrating B-Cells Suggest the Existence of Immune Regulatory Mechanisms in Islet Milieu Diabetes, April 1, 2007; 56(4): 940 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Kim, E. Y. Kim, J. Cerny, and K. D. Moudgil Antibody Responses to Mycobacterial and Self Heat Shock Protein 65 in Autoimmune Arthritis: Epitope Specificity and Implication in Pathogenesis J. Immunol., November 15, 2006; 177(10): 6634 - 6641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Silveira, H. D. Chapman, J. Stolp, E. Johnson, S. L. Cox, K. Hunter, L. S. Wicker, and D. V. Serreze Genes within the Idd5 and Idd9/11 Diabetes Susceptibility Loci Affect the Pathogenic Activity of B Cells in Nonobese Diabetic Mice J. Immunol., November 15, 2006; 177(10): 7033 - 7041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sblattero, F. Maurano, G. Mazzarella, M. Rossi, S. Auricchio, F. Florian, F. Ziberna, A. Tommasini, T. Not, A. Ventura, et al. Characterization of the Anti-Tissue Transglutaminase Antibody Response in Nonobese Diabetic Mice J. Immunol., May 1, 2005; 174(9): 5830 - 5836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Carrillo, M. C. Puertas, A. Alba, R. M. Ampudia, X. Pastor, R. Planas, N. Riutort, N. Alonso, R. Pujol-Borrell, P. Santamaria, et al. Islet-infiltrating B-Cells in Nonobese Diabetic Mice Predominantly Target Nervous System Elements Diabetes, January 1, 2005; 54(1): 69 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kubosaki, S. Gross, J. Miura, K. Saeki, M. Zhu, S. Nakamura, W. Hendriks, and A. L. Notkins Targeted Disruption of the IA-2{beta} Gene Causes Glucose Intolerance and Impairs Insulin Secretion but Does Not Prevent the Development of Diabetes in NOD Mice Diabetes, July 1, 2004; 53(7): 1684 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Falcone, F. Facciotti, N. Ghidoli, P. Monti, S. Olivieri, L. Zaccagnino, E. Bonifacio, G. Casorati, F. Sanvito, and N. Sarvetnick Up-Regulation of CD1d Expression Restores the Immunoregulatory Function of NKT Cells and Prevents Autoimmune Diabetes in Nonobese Diabetic Mice J. Immunol., May 15, 2004; 172(10): 5908 - 5916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. YU, G. EISENBARTH, E. BONIFACIO, J. THOMAS, M. ATKINSON, and C. WASSERFALL The Second Murine Autoantibody Workshop: Remarkable Interlaboratory Concordance for Radiobinding Assays to Identify Insulin Autoantibodies in Nonobese Diabetic Mice Ann. N.Y. Acad. Sci., November 1, 2003; 1005(1): 1 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. EISENBARTH Insulin Autoimmunity: Immunogenetics/Immunopathogenesis of Type 1A Diabetes Ann. N.Y. Acad. Sci., November 1, 2003; 1005(1): 109 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Jaeckel, L. Klein, N. Martin-Orozco, and H. von Boehmer Normal Incidence of Diabetes in NOD Mice Tolerant to Glutamic Acid Decarboxylase J. Exp. Med., June 16, 2003; 197(12): 1635 - 1644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Thomas, P. L. Kendall, and H. G. Mitchell The Natural Autoantibody Repertoire of Nonobese Diabetic Mice Is Highly Active J. Immunol., December 1, 2002; 169(11): 6617 - 6624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Noorchashm, S. A.W. Greeley, A. Naji, N. R. Farid, B. O. Roep, H. Kolb, and S. Martin B-Cell Deficiency and Type 1 Diabetes N. Engl. J. Med., February 14, 2002; 346(7): 538 - 539. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |